Literature DB >> 27819143

Evolution of phage display technology: from discovery to application.

Leila Rahbarnia1,2, Safar Farajnia1, Hossein Babaei1, Jafar Majidi3, Kamal Veisi4, Vahideh Ahmadzadeh1, Bahman Akbari5.   

Abstract

Phage display technology as a selection-based system is an attractive method for evolution of new biological drugs. Unique ability of phage libraries for displaying proteins on bacteriophage surfaces enable them to make a major contribution in diverse fields of researches related to the diagnosis and therapy of diseases. One of the great challenges facing researchers is the modification of phage display technology and the development of new applications. This article reviews the molecular basis of phage display library, and summarizes the novel and specific applications of this technique in the field of biological drugs development including therapeutic antibodies, peptides, vaccines, and catalytic antibodies.

Entities:  

Keywords:  Bacteriophages; abzyme; antibody; drug discovery; peptide; phage library; vaccine

Mesh:

Year:  2016        PMID: 27819143     DOI: 10.1080/1061186X.2016.1258570

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  13 in total

1.  A KLVFFAE-Derived Peptide Probe for Detection of Alpha-Synuclein Fibrils.

Authors:  Amy Wood; Edward Chau; Yanxi Yang; Jin Ryoun Kim
Journal:  Appl Biochem Biotechnol       Date:  2019-11-27       Impact factor: 2.926

2.  A New Fusion Peptide Targeting Pancreatic Cancer and Inhibiting Tumor Growth.

Authors:  Lei Zheng; Bo Zhang; Xiaoman He; Guodong Cao; Yongzhou Li; Kailun Cai; Bin Yang; Yulian Wu
Journal:  Onco Targets Ther       Date:  2020-08-12       Impact factor: 4.147

Review 3.  Current trends in targeted therapy for drug-resistant infections.

Authors:  Leila Rahbarnia; Safar Farajnia; Behrooz Naghili; Vahideh Ahmadzadeh; Kamal Veisi; Roghayyeh Baghban; Sayna Toraby
Journal:  Appl Microbiol Biotechnol       Date:  2019-08-14       Impact factor: 4.813

4.  Retrospective analysis of the preparation and application of immunotherapy in cancer treatment (Review).

Authors:  Jiachen Lu; Jianing Ding; Zhaoxia Liu; Tingtao Chen
Journal:  Int J Oncol       Date:  2022-01-04       Impact factor: 5.650

Review 5.  Emulating interactions between microorganisms and tumor microenvironment to develop cancer theranostics.

Authors:  Tongmeng Jiang; Tao Yang; Yingfan Chen; Yao Miao; Yajing Xu; Honglin Jiang; Mingying Yang; Chuanbin Mao
Journal:  Theranostics       Date:  2022-03-14       Impact factor: 11.600

6.  The Screen of a Phage Display Library Identifies a Peptide That Binds to the Surface of Trypanosoma cruzi Trypomastigotes and Impairs Their Infection of Mammalian Cells.

Authors:  Jéssica I de Paula; Eduardo J Lopes-Torres; Marcelo Jacobs-Lorena; Marcia Cristina Paes; Sung-Jae Cha
Journal:  Front Microbiol       Date:  2022-03-10       Impact factor: 5.640

Review 7.  Brief introduction of current technologies in isolation of broadly neutralizing HIV-1 antibodies.

Authors:  Zehua Sun; Lixin Yan; Jiansong Tang; Qian Qian; Jerica Lenberg; Dandan Zhu; Wan Liu; Kao Wu; Yilin Wang; Shiqiang Lu
Journal:  Virus Res       Date:  2017-10-16       Impact factor: 3.303

Review 8.  Viral Related Tools against SARS-CoV-2.

Authors:  Laura Fernandez-Garcia; Olga Pacios; Mónica González-Bardanca; Lucia Blasco; Inés Bleriot; Antón Ambroa; María López; German Bou; Maria Tomás
Journal:  Viruses       Date:  2020-10-16       Impact factor: 5.048

9.  The biologically functional identification of a novel TIM3-binding peptide P26 in vitro and in vivo.

Authors:  Tangwu Zhong; Chuanke Zhao; Shuntao Wang; Deshuang Tao; Shuxia Ma; Chengchao Shou
Journal:  Cancer Chemother Pharmacol       Date:  2020-10-21       Impact factor: 3.333

Review 10.  Mimotopes for Mycotoxins Diagnosis Based on Random Peptides or Recombinant Antibodies from Phage Library.

Authors:  Wei Sun; Yan Zhang; Zhigang Ju
Journal:  Molecules       Date:  2021-12-17       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.